Pharmaceutical Care for a High Paraplegia Patient with Hospital Acquired Pneumonia
10.6039/j.issn.1001-0408.2015.26.42
- VernacularTitle:1例高位截瘫伴医院获得性肺炎患者的药学监护
- Author:
Qiaoying ZENG
;
Dongmei JIA
- Publication Type:Journal Article
- Keywords:
Clinical pharmacist;
High paraplegia;
Hospital acquired pneumonia;
Pharmaceutical care
- From:
China Pharmacy
2015;(26):3729-3730,3731
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the role of clinical pharmacists in the treatment of high paraplegia patient with hospital acquired pneumonia. METHODS:Clinical pharmacists provided suggestions for anti-infective treatment failure of a high paraplegia patient with hospital acquired pneumonia,including anti-infective treatment of imipenem and cilastatin sodi-um 1.0 g,ivgtt,qid,de-escalation anti-infective treatment of cefoperazone sodium and sulbactam sodium 3.0 g,ivgtt,bid+amikacin 0.4 g,ivgtt,bid,and prevention treatment of fluconazole sodium chloride 0.2 g,ivgtt,qd against potential invasive infections with fungi,etc.,assisted physician to improve therapy plan,monitor ADR and guide rational drug use. RE-SULTS:After 3 weeks of treatment,the symptoms had been improved significantly. CONCLUSIONS:Clinical pharmacists provide individual pharmaceutical care to reduce ADR during treatment and improve the effectiveness and safety of clinical treatment.
